Rough Rice (ZR March 2025)/ ECBOT
ZR2024-11-15 8:14:29 PM | Chg. +0.365 | Bid8:21:29 PM | Ask8:21:29 PM | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
15.230USD | +2.46% | 15.175 | 15.245 | 14.885 | 15.300 | 14.860 | 14.865 |
GlobeNewswire
08-22
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Prior...
GlobeNewswire
08-21
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in...
GlobeNewswire
08-14
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR...
GlobeNewswire
08-09
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
Newsfile Corp
07-09
Teako Mobilizes Field Crew to Copper-Cobalt-Zinc Projects Lomunda-Venna and Tydalen Utilizing Recent...
GlobeNewswire
07-09
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmace...
GlobeNewswire
06-25
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
GlobeNewswire
06-20
Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024
GlobeNewswire
06-10
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead C...
GlobeNewswire
06-05
TRIUMPH UNVEILS LIMITED EDITION MY25 SPEED TRIPLE 1200 RR IN COLLABORATION WITH BREITLING
GlobeNewswire
05-23
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
05-09
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire
05-02
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval fo...
GlobeNewswire
04-18
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Im...